Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease is a research paper published in Cancer (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: K08CA226237
National Institutes of Health
Grant: P30CA014599
National Institutes of Health
Grant: 1K08CA226237-01
Elucidating transcription regulation by epigenetics in neuroblastoma
National Institutes of Health
Grant: 3P30CA014599-36S1
Cancer Center Support Grant
Influential Citations
1
Fields of Study
Keywords
Sustainable Development Goals